Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ikuta, K.
Right arrow Articles by Weissman, I. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ikuta, K.
Right arrow Articles by Weissman, I. L.

International Journal of Cell Cloning, Vol 9, 451-460, Copyright © 1991 by AlphaMed Press


REVIEWS

Mouse hematopoietic stem cells and the interaction of c-kit receptor and steel factor

K Ikuta, DE Ingolia, J Friedman, S Heimfeld and IL Weissman
Howard Hughes Medical Institute, Stanford, California.

Hematopoietic stem cells (HSCs) are distinguished from other hematopoietic progenitors in bone marrow by their unique ability to undergo multilineage differentiation and self-renewal. Two mouse mutations, dominant spotting (W) and steel (Sl), have pleiotropic effects on hematopoiesis, gametogenesis, and melanoblast development. These two mutations have been shown to be intrinsic (W) and microenvironmental (Sl) defects. Recently, molecular studies revealed that the W and Sl loci encode the c-kit receptor and steel factor (SLF), respectively. The c-kit receptor is expressed on HSCs and hematopoietic progenitors, while SLF is produced by stromal cells. SLF acts on hematopoietic progenitors synergistically with other growth factors. Here we review the effect of these mutations on mouse hematopoiesis, and show that SLF acts on HSCs and other myeloerythroid progenitors, but that it, in our hands, does not play a critical role in HSC generation or self-renewal. Rather, SLF is the most potent co- mitogen (with IL-1, IL-3, IL-6, G-CSF, GM-CSF, or M-CSF) found that acts on these cells, but the effect of such treatments is the rather specific and massive expansion of myeloerythropoiesis, not lymphopoiesis, and perhaps at the expense of HSC self-renewal.


This article has been cited by other articles:


Home page
BloodHome page
C. Desponts, A. L. Hazen, K. H. T. Paraiso, and W. G. Kerr
SHIP deficiency enhances HSC proliferation and survival but compromises homing and repopulation
Blood, June 1, 2006; 107(11): 4338 - 4345.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. Domen and I. L. Weissman
Hematopoietic Stem Cells Need Two Signals to Prevent Apoptosis; BCL-2 Can Provide One of These, Kitl/c-Kit Signaling the Other
J. Exp. Med., December 11, 2000; 192(12): 1707 - 1718.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
Email Content Delivery
Copyright © 1991 by AlphaMed Press.